Skip to Content

Technologies | Pharmaceutical

PPG’s deep understanding of the industry drives us to protect clients’ IP, commercialize their discoveries, and attract investment.

Our lawyers appreciate the interplay between the business and science of drug discovery—from the high-stakes world of financing R&D to the rigorous regulatory process for new products. Since our team has advanced degrees and extensive experience across the pharmaceutical industry, we understand the value of our client’s discovery. This combined expertise affords our clients a crucial edge in navigating this complex and constantly evolving legal environment.

Our approach:
  • Commit to understanding each client’s unique business and goals.
  • Build proactive strategies that minimize risk and deliver superior outcomes.
  • Leverage the right mix of intellectual property counsel, from strategic counseling to patent prosecution, due diligence, legal opinions, and litigation support.
  • Work collaboratively, listen well, and engage thoroughly.
  • Achieve results others can not envision


Pharmaceutical IP Services


Services we have provided our pharmaceutical industry clients include:
  • IP strategy development
  • IP audit and landscape analysis
  • Prosecuting and filing patent applications in the U.S. and foreign jurisdictions
  • Representation in patent interferences, reexamination proceedings, and international oppositions
  • Litigation support
  • Due diligence for mergers, acquisitions, and partnering
  • Drafting and negotiating license agreements
  • Trademark prosecution and counseling
Below are exemplary patents that we have obtained for our clients in the pharmaceutical industry:
 
  • US Patent no. 11,116,737 “Methods of using probenecid for treatment of coronavirus infections” assigned to University of Georgia Research Foundation
  • US Patent no. 10,953,036 “Compositions and methods of modulating HIF-2A to improve muscle generation and repair” assigned to University of Georgia Research Foundation
  • US Patent no. 10,912,834 “Topical Formulations based on Ionic Species for Skin Treatment” assigned to The Regents of the University of California
  • US Patent no. 10,828,265 “Formulations of propranolol and analogs as an amorphous melt or ionic liquid for transdermal drug delivery” assigned to The Regents of the University of California
  • US Patent no. 10,722,468 “Compositions for Stabilizing and Delivering Proteins” assigned to Brown University
  • US Patent no. 10,653,789 “Polymer-drug conjugates for combination anticancer therapy” assigned to The Regents of the University of California
Technologies